Vaniprevir ( MK-@ ) is a hepatitis C virus ( HCV ) non-structural @/@a protease inhibitor which significantly increases virologic response rates in HCV genotype ( GT ) @-infected patients when added to peginterferon and ribavirin ( PR ) .